title: Dermatological side-effects in hepatitis C infected patients under a triple regimen associating pegylated interferon, ribavirin and telaprevir.
authors.affiliation: Department of Dermatology, Assistance-Publique-Hôpitaux de Paris, Groupe Hospitalier Cochin, Paris, France.|Université Paris Descartes, Paris, France.
authors.forename: C
authors.initials: C
authors.lastname: Bernardeschi
authors.affiliation: Department of Dermatology, Referral center for toxic bullous diseases, Assistance-Publique-Hopitaux de Paris, Hôpital Henri Mondor, Créteil, France.|Université Paris Est, Créteil, France.
authors.forename: L
authors.initials: L
authors.lastname: Valeyrie-Allanore
authors.affiliation: Université Paris Est, Créteil, France.|Department of Pathology, Assistance-Publique-Hôpitaux de Paris, Hôpital Henri Mondor, Créteil, France.
authors.forename: N
authors.initials: N
authors.lastname: Ortonne
authors.affiliation: Department of Dermatology, Assistance-Publique-Hôpitaux de Paris, Groupe Hospitalier Cochin, Paris, France.|Université Paris Descartes, Paris, France.
authors.forename: L
authors.initials: L
authors.lastname: Gressier
authors.affiliation: Department of Dermatology, Assistance-Publique-Hôpitaux de Paris, Groupe Hospitalier Cochin, Paris, France.|Université Paris Descartes, Paris, France.
authors.forename: N
authors.initials: N
authors.lastname: Wallet-Faber
authors.affiliation: Department of Hepatology, Hôpital Saint-André, Bordeaux, France.
authors.forename: P-H
authors.initials: PH
authors.lastname: Bernard
authors.affiliation: Université Paris Est, Créteil, France.|Department of Hepatology, Assistance-Publique-Hôpitaux de Paris, Hôpital Henri Mondor, Creteil, France.
authors.forename: C
authors.initials: C
authors.lastname: Hezode
authors.affiliation: Department of Hepatology, Assistance-Publique-Hôpitaux de Paris, Hôpital Paul Brousse, France.
authors.forename: J-C
authors.initials: JC
authors.lastname: Duclos-Vallée
authors.affiliation: Department of Hepatology, Assistance-Publique-Hôpitaux de Paris, Hôpital Paul Brousse, France.
authors.forename: D
authors.initials: D
authors.lastname: Samuel
authors.affiliation: Université Paris Descartes, Paris, France.|Department of Hepatology, Assistance-Publique-Hôpitaux de Paris, Groupe Hospitalier Cochin, Paris, France.
authors.forename: V
authors.initials: V
authors.lastname: Mallet
authors.affiliation: Université Paris Descartes, Paris, France.|Department of Hepatology, Assistance-Publique-Hôpitaux de Paris, Groupe Hospitalier Cochin, Paris, France.
authors.forename: S
authors.initials: S
authors.lastname: Pol
authors.affiliation: Department of Dermatology, Hôpital Saint-André Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
authors.forename: B
authors.initials: B
authors.lastname: Milpied
authors.affiliation: Department of Dermatology, Assistance-Publique-Hôpitaux de Paris, Groupe Hospitalier Cochin, Paris, France.|Université Paris Descartes, Paris, France.
authors.forename: N
authors.initials: N
authors.lastname: Dupin
mesh_terms: D000368:Aged; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001706:Biopsy; D003875:Drug Eruptions / Q000175:diagnosis*; D005260:Female; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000009:adverse effects* / Q000627:therapeutic use; D011446:Prospective Studies; D012254:Ribavirin / Q000009:adverse effects* / Q000627:therapeutic use; D012307:Risk Factors
chemical_list: D000998:Antiviral Agents; D009842:Oligopeptides; D012254:Ribavirin; C486464:telaprevir; D007372:Interferons